[go: up one dir, main page]

WO2008071910A3 - Acétylation - Google Patents

Acétylation Download PDF

Info

Publication number
WO2008071910A3
WO2008071910A3 PCT/GB2007/004598 GB2007004598W WO2008071910A3 WO 2008071910 A3 WO2008071910 A3 WO 2008071910A3 GB 2007004598 W GB2007004598 W GB 2007004598W WO 2008071910 A3 WO2008071910 A3 WO 2008071910A3
Authority
WO
WIPO (PCT)
Prior art keywords
acetylation
cytokeratin
detection
hdac5
cytokeratins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2007/004598
Other languages
English (en)
Other versions
WO2008071910A2 (fr
Inventor
Bernard Corfe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sheffield
Original Assignee
University of Sheffield
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sheffield filed Critical University of Sheffield
Publication of WO2008071910A2 publication Critical patent/WO2008071910A2/fr
Publication of WO2008071910A3 publication Critical patent/WO2008071910A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4742—Keratin; Cytokeratin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention porte sur la détection de l'état d'acétylation des cytokératines 8 et/ou 18 dans un échantillon biologique, et servant d'outil diagnostique et/ou pronostique de maladies et aussi d'agents thérapeutiques modulant l'état d'acétylation des cytokératines 8 et/ou 18.
PCT/GB2007/004598 2006-12-11 2007-11-30 Acétylation Ceased WO2008071910A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0624745A GB0624745D0 (en) 2006-12-11 2006-12-11 Acetylation
GB0624745.6 2006-12-11

Publications (2)

Publication Number Publication Date
WO2008071910A2 WO2008071910A2 (fr) 2008-06-19
WO2008071910A3 true WO2008071910A3 (fr) 2009-04-02

Family

ID=37711958

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2007/004598 Ceased WO2008071910A2 (fr) 2006-12-11 2007-11-30 Acétylation

Country Status (2)

Country Link
GB (1) GB0624745D0 (fr)
WO (1) WO2008071910A2 (fr)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002050285A2 (fr) * 2000-12-20 2002-06-27 Novartis Ag Gene et proteine lies a une histone deacetylase
WO2002102323A2 (fr) * 2001-06-14 2002-12-27 Bristol-Myers Squibb Company Nouvelles histones deacetylases humaines
WO2003045405A2 (fr) * 2001-11-27 2003-06-05 Bio-K Plus International Inc. Bacteries lactiques et leur usage dans le traitement et la prevention du cancer
US20030129724A1 (en) * 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
US20040022869A1 (en) * 2001-11-30 2004-02-05 Chen Lan Bo Methods and compositions for modulating the immune system and uses thereof
US20040266718A1 (en) * 2001-08-06 2004-12-30 Zuomei Li Inhibition of specific histone deacetylase isoforms
WO2005016126A2 (fr) * 2003-08-15 2005-02-24 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Analyse multifactorielle pour la detection du cancer
EP1586903A1 (fr) * 2004-03-30 2005-10-19 Sysmex Corporation Méthode de dépistage du cancer du col de l'utérus

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030129724A1 (en) * 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
WO2002050285A2 (fr) * 2000-12-20 2002-06-27 Novartis Ag Gene et proteine lies a une histone deacetylase
WO2002102323A2 (fr) * 2001-06-14 2002-12-27 Bristol-Myers Squibb Company Nouvelles histones deacetylases humaines
US20040266718A1 (en) * 2001-08-06 2004-12-30 Zuomei Li Inhibition of specific histone deacetylase isoforms
WO2003045405A2 (fr) * 2001-11-27 2003-06-05 Bio-K Plus International Inc. Bacteries lactiques et leur usage dans le traitement et la prevention du cancer
US20040022869A1 (en) * 2001-11-30 2004-02-05 Chen Lan Bo Methods and compositions for modulating the immune system and uses thereof
WO2005016126A2 (fr) * 2003-08-15 2005-02-24 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Analyse multifactorielle pour la detection du cancer
EP1586903A1 (fr) * 2004-03-30 2005-10-19 Sysmex Corporation Méthode de dépistage du cancer du col de l'utérus

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DORMEYER WILMA ET AL: "Probing lysine acetylation in proteins: strategies, limitations, and pitfalls of in vitro acetyltransferase assays.", MOLECULAR & CELLULAR PROTEOMICS : MCP SEP 2005, vol. 4, no. 9, September 2005 (2005-09-01), pages 1226 - 1239, XP002480863, ISSN: 1535-9476 *
GIBBS P E ET AL: "Differential post-translational modification of human type I keratins synthesized in a rabbit reticulocyte cell-free system.", BIOCHIMICA ET BIOPHYSICA ACTA 20 MAR 1985, vol. 824, no. 3, 20 March 1985 (1985-03-20), pages 247 - 255, XP002480862, ISSN: 0006-3002 *
GIBSON P R: "The intracellular target of butyrate's actions: HDAC or HDON'T?", GUT APR 2000, vol. 46, no. 4, April 2000 (2000-04-01), pages 447 - 448, XP002505610, ISSN: 0017-5749 *
KOUZARIDES T: "Acetylation: a regulatory modification to rival phosphorylation?", THE EMBO JOURNAL 15 MAR 2000, vol. 19, no. 6, 15 March 2000 (2000-03-15), pages 1176 - 1179, XP002480864, ISSN: 0261-4189 *
OMARY M B ET AL: "Keratin modifications and solubility properties in epithelial cells and in vitro", SUB-CELLULAR BIOCHEMISTRY,, vol. 31, 1 January 1998 (1998-01-01), pages 105 - 140, XP009099742, ISSN: 0306-0225 *
SCHEPPACH W ET AL: "Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis.", GASTROENTEROLOGY JUL 1992, vol. 103, no. 1, July 1992 (1992-07-01), pages 51 - 56, XP009100496, ISSN: 0016-5085 *

Also Published As

Publication number Publication date
WO2008071910A2 (fr) 2008-06-19
GB0624745D0 (en) 2007-01-17

Similar Documents

Publication Publication Date Title
AU2006316189A8 (en) Novel quantitative and qualitative analysis apparatus for measuring the body fluid
EP2989981B8 (fr) Cartouche d'échantillonnage et d'analyse de fluide corporel multi-sites
EP1980203B8 (fr) Capteur sanguin et appareil d'analyse sanguine en etant equipe
PL3026874T3 (pl) Składnik do badania płynu ustrojowego do detekcji analitu
GB0521521D0 (en) Diagnostic methods and kits
IL189499A0 (en) Diaminopyrimidines as p2x3 and p2x2/3 modulators
WO2007114986A3 (fr) Sondes coopératives et leurs procédés d'utilisation
WO2005051178A3 (fr) Marqueur pour la neuromyelite optique
EP1931800A4 (fr) Systemes et methodes d'enrichissement d'analytes
EP2535718A3 (fr) Procédé de diagnostic précoce de maladie rénale
AU2002364120A1 (en) Sensor for the use in testing biological chemical or environmental samples
EP2239573A3 (fr) Dérivés et conjugués de doxorubicin pour l'immunodosage dudit
WO2009082445A3 (fr) Nouveaux dispositifs pour la détection de la présence et/ou de l'activité de protéases dans des échantillons biologiques
PL2093134T3 (pl) Urządzenie do wykrywania i wskazywania pozycji elementów składowych sprzęgów pojazdów
PL1774356T3 (pl) Sposób oznaczania lipoprotein w płynach ustrojowych
EP2564864B8 (fr) Méthodes associées au FGF2 pour diagnostiquer et traiter une dépression
GB0524681D0 (en) Multiport Calibration Simplification using the "Unknown Thru" method
EG24996A (en) Reel and device for identifying properties of the reel material.
WO2007056288A3 (fr) Methodes d'evaluation de baff
WO2008071910A3 (fr) Acétylation
AP2356A (en) Apparatus for determining the presence of a contaminant in a sample of water or other fluid.
WO2005118881A3 (fr) Tests de depistage de la maladie polykystique renale chez le chat
GB0507162D0 (en) Diagnostic markers and assays for the detection of the same
GB0508344D0 (en) Diagnostic markers and assays for the detection of the same
EP1904106A4 (fr) Reactifs pour la detection d'atr kinase phosphorylee (ser 428/ser 2317) et utilisations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07848419

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07848419

Country of ref document: EP

Kind code of ref document: A2